The store will not work correctly when cookies are disabled.
[5-(4-Aminomethyl-thiophene-2-carbonyl)-1H-benzoimidazol-2-yl]-carbamic acid methyl ester
ID: ALA336324
PubChem CID: 44354347
Max Phase: Preclinical
Molecular Formula: C15H14N4O3S
Molecular Weight: 330.37
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COC(=O)Nc1nc2cc(C(=O)c3cc(CN)cs3)ccc2[nH]1
Standard InChI: InChI=1S/C15H14N4O3S/c1-22-15(21)19-14-17-10-3-2-9(5-11(10)18-14)13(20)12-4-8(6-16)7-23-12/h2-5,7H,6,16H2,1H3,(H2,17,18,19,21)
Standard InChI Key: XGSRCSPKGNSPMJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
6.5417 -6.6000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0542 -5.9292 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4250 -6.1917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0542 -7.2667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.3667 -6.5917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.2750 -6.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6667 -5.8542 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
3.1375 -5.7792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3375 -7.0042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9542 -6.0125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2750 -7.0167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8500 -6.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5292 -7.1792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1167 -6.4667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5542 -5.7750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7375 -5.2125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8500 -7.0167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1292 -4.9500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.5542 -7.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7500 -6.2250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.6792 -8.6000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.1917 -7.9375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3292 -5.6417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 8 1 0
4 1 1 0
5 1 1 0
6 2 1 0
7 3 1 0
8 12 1 0
9 3 2 0
10 5 1 0
11 4 1 0
12 15 1 0
13 9 1 0
14 7 1 0
15 6 2 0
16 10 2 0
17 19 1 0
18 8 2 0
19 11 2 0
20 10 1 0
21 22 1 0
22 13 1 0
23 20 1 0
11 6 1 0
12 17 2 0
13 14 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 330.37 | Molecular Weight (Monoisotopic): 330.0787 | AlogP: 2.49 | #Rotatable Bonds: 4 |
Polar Surface Area: 110.10 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.22 | CX Basic pKa: 8.44 | CX LogP: 1.96 | CX LogD: 1.12 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.64 | Np Likeness Score: -1.15 |
References
1. Kruse LI, Ladd DL, Harrsch PB, McCabe FL, Mong SM, Faucette L, Johnson R.. (1989) Synthesis, tubulin binding, antineoplastic evaluation, and structure-activity relationship of oncodazole analogues., 32 (2): [PMID:2913301] [10.1021/jm00122a020] |